20 May 2013
Keywords: dyax, deal, astrazeneca, antibody, discovery, corp, usa
Article | 20 May 2002
Dyax Corp of the USA has announced a collaboration and license agreementwith drug major AstraZeneca that involves Dyax's proprietary antibody
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 May 2002
13 May 2002
© 2013 thepharmaletter.com